PRESSRELEASES
21 February, 2024
Nanexa publishes year-end report and Q4 report 2023
NEX-22 clinical trial application submitted, secured funding and tactical priorities for 2024
READ MORE20 February, 2024
Invitation to presentation of Nanexa’s year-end report and Q4 report 2023
Nanexa AB (publ) publishes tomorrow, February 21, 2024, its year-end report for the financial year 2023 and interim report for the fourth quarter of 2023 and invites to a report commentary.
READ MORELATEST REPORTS
PRESENTATIONS
2024-03-08
ABG Sundal Collier – Fireside chat with CEO David Westberg
2023-10-24
Aktieportföljen Live, CEO David Westberg presents
2023-10-09
Aktiespararna, Aktiedagen Lund, CEO David Westberg presents
MEET NANEXA
Inga planerade träffar